How did GOVX's R&D costs trend over 2023-2024?
4/14/2025 02:10pm
GeoVax Labs (GOVX) consistently increased its Research and Development (R&D) expenses over the course of 2023 and 2024, with a cumulative expenditure of $20.72 million by the end of 2024. This indicates a strong commitment to innovation and product development during this period.
|code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code|
|---|---|---|---|---|---|---|
|GOVX|GOVX.O|GeoVax Labs|2023 Q1|2819189|111.88243304994047|186|
|GOVX|GOVX.O|GeoVax Labs|2023 Q2|4719728|261.0626563961881|186|
|GOVX|GOVX.O|GeoVax Labs|2023 Q3|6947979|155.32813512881836|186|
|GOVX|GOVX.O|GeoVax Labs|2023 Q4|6233870|65.59350065160304|186|
|GOVX|GOVX.O|GeoVax Labs|2024 Q1|4425728|56.985856570808124|186|
|GOVX|GOVX.O|GeoVax Labs|2024 Q2|4276868|-9.383167843570646|186|
|GOVX|GOVX.O|GeoVax Labs|2024 Q3|7402884|6.54729958164813|186|
|GOVX|GOVX.O|GeoVax Labs|2024 Q4|7608122|22.04492554384355|186|